Beverly Hills surgeon Emil Kohan faces scrutiny over a dismissed malpractice claim, an unresolved federal trademark dispute, and unverified corporate ties worth examining.
Board-Certified Plastic and Reconstructive Surgeon, Beverly Hills, CA
Primary Jurisdictions
California, United States
Investigation Period
2018–2024
Methodology
Open-source investigation drawing on California Superior Court dockets, federal PACER docket records, Cedars-Sinai provider directory, media reporting, and directory sources. All adverse claims are attributed to specific source documents with evidence-class labels. Automated scanner output is disaggregated into component matters and is not treated as an independent editorial finding. Primary-source verification gaps are explicitly identified.
Key findings from the OSINT investigation. All allegations are unproven unless legally established.
Emil J. Kohan, M.D. is a Beverly Hills plastic and reconstructive surgeon operating through Emil Kohan M.D. Inc. at 421 N. Rodeo Drive, with a confirmed Cedars-Sinai Medical Center provider listing. Three civil matters from 2018–2019 were identified: a malpractice claim dismissed pre-trial (no liability finding), a federal competitor trademark action with unconfirmed resolution, and a landlord-side lease dispute. No criminal, regulatory, or enforcement findings identified. Risk classification: borderline low, watch notation only.
Emil J. Kohan, M.D. is a board-certified plastic and reconstructive surgeon operating from 421 N. Rodeo Drive, Beverly Hills, California, through his professional medical corporation Emil Kohan M.D. Inc. He holds a confirmed provider listing with Cedars-Sinai Medical Center. The adverse record identified in this investigation is narrow and historically bounded, consisting of three civil matters originating in 2018, all dormant since 2019–2021 with no active proceedings identified.
The three civil matters are: a state-court medical malpractice claim by patient Meredith Gross (Los Angeles Superior Court case BC721131), dismissed prior to trial with no finding of liability; a federal trademark and trade dress action filed by corporate plaintiff Lipoplus Inc. (C.D. Cal. 2:2018cv10220), with resolution status unconfirmed in available public sources pending PACER verification; and a commercial lease dispute surfaced in connected media coverage in January 2019. No criminal charges, regulatory enforcement actions, California Medical Board disciplinary findings, sanctions-list entries, or professional licensing restrictions have been identified across any search angle. The overall risk posture is borderline-low, qualifying for a watch-level notation only. The principal analytical risk in this profile is scanner-generated overstatement of routine civil litigation.
Civil Matters Identified
Three civil matters from 2018–2019: one dismissed malpractice claim, one federal trademark action with unconfirmed resolution, and one landlord-side commercial lease dispute. All dormant as of available research.
Active Proceedings
No active court, regulatory, enforcement, or licensing proceedings identified in the supplied research. Structural zero reflects verified absence in available sources, not a universal guarantee.
Entities Identified
Two named corporate entities: Emil Kohan MD Inc. (confirmed professional medical corporation) and Roxbury Surgical Institute Inc. (litigation co-defendant; ownership link to subject unconfirmed).
Risk Classification
Based on AML exposure, offshore structures & PEP associations
No family relationships, spousal connections, or relative business associations have been established in the supplied research for Emil J. Kohan, M.D. The investigation did not surface family member names, household property ownership, or kin-based corporate structures in any searched public record.
No beneficial ownership link between Kohan and Roxbury Surgical Institute Inc., the co-defendant in BC721131, has been confirmed. That entity appears as a co-named litigation party only. California Secretary of State corporate records for both Emil Kohan M.D. Inc. and Roxbury Surgical Institute Inc. have not been retrieved and reviewed as a primary source; the ownership relationship remains an open evidentiary gap.
Emil Kohan M.D. Inc.
Kohan's California-registered professional medical corporation, through which his Beverly Hills plastic surgery practice operates at 421 N. Rodeo Drive. Named as a defendant alongside Kohan personally in Los Angeles Superior Court case BC721131 (2018). [VERIFIED PUBLIC — California Superior Court docket, Trellis.law]
Plastic and Reconstructive Surgery Practice — 421 N. Rodeo Drive
The subject's primary clinical practice location in Beverly Hills, California. Address confirmed through court filings and public directory sources. [VERIFIED PUBLIC — court docket; REPORTED — directory sources]
Cedars-Sinai Medical Center Provider Affiliation
Kohan holds a confirmed provider listing with Cedars-Sinai Medical Center as of the date of the supply research. Whether this reflects current active clinical privileges or a historical directory entry has not been independently verified through Cedars-Sinai credentialing. [VERIFIED PUBLIC — Cedars-Sinai.org provider directory]
Roxbury Surgical Institute Inc. — Litigation Co-Defendant
Named alongside Kohan and Emil Kohan M.D. Inc. as a co-defendant in BC721131. The nature of Kohan's ownership, control, or employment relationship with this entity is unconfirmed in the supplied research. A discrepancy between the name 'Roxbury Surgical Institute Inc.' in the case caption and 'Rodeo Surgical Institute Inc.' surfaced in a directory source has not been resolved. California SOS verification is an open gap. [VERIFIED PUBLIC — court caption; UNVERIFIED — ownership relationship]
Self-Described Clinical Practice Brand — emilmd.com
The subject maintains a practice website asserting credentials including UCLA medical school education, UC Irvine post-graduate training, ABPS board certification, and peer-reviewed publications. These claims have not been independently verified against primary certification or academic sources and are treated as subject's own assertions for PR-versus-record baseline purposes only. [UNVERIFIED — subject's own website, not an independent corroborating source]
Click an event for full details
Select a milestone to view details
Kohan's practice website asserts UCLA medical school education. This claim has not been independently verified against UCLA records or a primary academic source. [UNVERIFIED — subject's own website only]
Career Overview
Corporate entity footprint is limited to one confirmed professional medical corporation. Co-defendant entity ownership link is unconfirmed. No offshore, holding, or layered structure identified.
No Russian entities identified
No Russian corporate registrations, asset ownership, or business relationships identified in the supplied research for this subject.
Not applicable
Subject operates exclusively within California, United States jurisdiction as a licensed medical professional.
Not applicable
Insufficient publicly available information to establish any Russia-linked entity or relationship.
No European entities identified
No European corporate registrations, asset ownership, or business relationships identified in the supplied research for this subject.
Not applicable
Subject's identified corporate footprint is limited to California-registered entities only.
Not applicable
Insufficient publicly available information to establish any European-linked entity or relationship.
Tap an entity to view details · Drag slider to explore changes over time
Civil matters filed
Select an entity
Click any node to view entity details, jurisdiction, and ownership notes.
Interactive visualization of alleged shell company operators and their network of liquidated entities. Click an operator to highlight connections.
0
Total Director Roles
0
Total Founder Roles
No liquidated entities identified in supplied research
Liquidation Rate
No financial layering, offshore flows, or suspicious financial activity identified in supplied research
Reported Financial Activity
Roxbury Surgical Institute Inc.
Ownership link unconfirmed
California SOS lookup is an open evidentiary gap; litigation co-defendant relationship only
Emil Kohan M.D. Inc.
California SOS not primary-source verified
Entity confirmed through court caption; registered agent, officers, and incorporation date not retrieved from primary source
No Offshore or Layered Structure
None identified
No offshore vehicles, holding companies, or UBO concealment identified in the supplied research
Key Concern
The only unresolved ownership dimension is the nature of the relationship between Kohan and Roxbury Surgical Institute Inc., which appears in BC721131 solely as a co-defendant. No beneficial ownership link has been confirmed or denied. California SOS verification is required before any ownership statement can be made. No offshore, shell, or multi-layered corporate structure has been identified in the supplied research.
Emil J. Kohan, M.D. is a private healthcare professional. No politically exposed person (PEP) designation, government appointment, elected office, or political associate network has been identified in the supplied research. No PEP classification applies.
No OFAC designation, UN sanctions-list entry, Treasury enforcement action, or equivalent sanctions-list hit has been identified across any search angle in the supplied research. No board action, disciplinary finding, or licensing restriction has been identified via available secondary sources (Healthgrades). Primary-source California Medical Board BreEZe lookup and NPDB inquiry have not been completed and remain open evidentiary gaps. Absence of secondary-source board-action notation is not equivalent to a confirmed clean primary-source regulatory record.
Medical Malpractice — BC721131 (Dismissed)
Patient Meredith Gross filed a medical malpractice claim in Los Angeles Superior Court in 2018 against Kohan and Emil Kohan M.D. Inc. The case was dismissed prior to trial by late 2019. No finding of liability was made against Kohan or his medical corporation. The dismissal instrument has not been retrieved; whether dismissal was with or without prejudice, or whether any payment accompanied resolution, is an open gap. This matter must not be characterized as an exoneration. [VERIFIED PUBLIC — Trellis.law; Docketalarm.com]
Federal Trademark and Trade Dress — 2:2018cv10220 (Resolution Unconfirmed)
Corporate plaintiff Lipoplus Inc. filed a federal trademark and trade dress action against Kohan in the Central District of California on December 7, 2018. The action alleged that Kohan's practice name misled patients. A spokesperson for Kohan's practice denied the allegations, characterizing the case as without validity, per The Real Deal LA (January 8, 2019). The named plaintiff is Lipoplus Inc., not Lloyd Krieger personally. Whether Krieger is an officer or principal of Lipoplus Inc. is unconfirmed. Resolution status is not confirmed in available public sources; PACER verification is an open gap. [VERIFIED PUBLIC — Justia.com docket; REPORTED — The Real Deal LA]
Commercial Lease Dispute — Rodeo Drive (Landlord-Side, Reported)
A commercial lease dispute involving the Rodeo Drive practice premises was reported in January 2019 media coverage. Bahador Mahboubi, the Rodeo Drive landlord, is described as the primary party in the landlord-side proceeding. Kohan's practice appears as a third party rather than the primary defendant in this dimension. Kohan's precise litigation role has not been confirmed through a primary court filing. [REPORTED — The Real Deal LA, January 8, 2019]
No Criminal, Regulatory, or Enforcement Findings
No criminal charges, arrest records, DEA enforcement actions, California Medical Board disciplinary orders, federal enforcement actions, sanctions-list entries, or professional licensing restrictions have been identified in the supplied research across any search angle. The absence of secondary-source board-action notation (Healthgrades) is noted; primary-source BreEZe and NPDB verification are open gaps and the absence of a secondary-source flag is not a confirmed clean regulatory record. [REPORTED — Healthgrades (secondary, not primary); primary-source verification gaps acknowledged]
Adverse media coverage is limited to one January 2019 article in The Real Deal LA, reporting on the federal trademark dispute and the landlord-side Rodeo Drive lease matter. No additional adverse media coverage has been identified beyond 2021. Automated scanner tools flagged this subject as named in multiple lawsuits; this advisory disaggregates that scanner output and does not adopt the scanner's characterization as an independent editorial finding. The scanner flag is an aggregation artifact. The underlying matters, properly decomposed, present a watch-level civil record, not a high-risk adverse media finding.
4 identified locations · Adverse media record: 1 article (The Real Deal LA, January 2019). No additional coverage identified beyond 2021.
Filter by Jurisdiction
4 properties — click a marker for details
1
Adverse media articles identified
January 2019
Adverse media coverage period
0 identified
Active adverse proceedings
3 civil matters
Scanner flags — decomposed to watch-level
The subject maintains a high-visibility public brand through social media, a luxury practice address, and institutional affiliation. No coordinated PR suppression campaign, reputation-management firm engagement, or deliberate content deletion has been identified in the supplied research. The promotional content observed is standard for a high-visibility cosmetic surgery practice in the Beverly Hills market.
The subject maintains a high-visibility public brand through social media, a luxury practice address, and institutional affiliation. No coordinated PR suppression campaign, reputation-management firm engagement, or deliberate content deletion has been identified in the supplied research. The promotional content observed is standard for a high-visibility cosmetic surgery practice in the Beverly Hills market.
Hover over any node to highlight its connections. The graph maps relationships between ventures, coordinated PR outlets, and targeted platforms.
Spokesperson denial of trademark allegations published contemporaneously in The Real Deal LA. No documented takedown request, NDA-enforced silence, or injunction against reporting identified in the supplied research. [REPORTED — The Real Deal LA]
All adverse civil matters became dormant consistent with case resolution and age. SERP is now dominated by promotional content. Dormancy is not evidence of active digital suppression in the absence of corroborating takedown or content-removal evidence. [INFERRED — not a confirmed suppression finding]
No coordinated reputation-management firm engagement, deliberate content deletion campaign, or SEO manipulation pattern has been identified in the supplied research. Absence of evidence is noted; a structured consumer platform sweep remains an open investigative gap.
Each public claim cross-referenced against available OSINT evidence. Click any row to expand.
All claims are derived from publicly available OSINT sources. This table does not assert legal wrongdoing. Click any row to expand evidence and analyst notes.
Key documented events in chronological order. Drag to scroll.
Scroll or drag to explore — click any event for detailsSwipe to explore — tap any event for details
8 documented events · 2018 – present (all adverse matters dormant since 2019–2021)
Four-quadrant risk assessment by impact severity and likelihood of exposure.
Federal Trademark Action — Resolution Unconfirmed
Lipoplus Inc. v. Kohan (2:2018cv10220, C.D. Cal.) was filed December 7, 2018. As of the last public docket retrieval (January 30, 2019), no resolution was recorded. PACER primary-source verification is required before any conclusion about outcome can be drawn. The case must not be presumed dismissed or settled without primary-source confirmation. [VERIFIED PUBLIC — Justia.com docket]
Roxbury Surgical Institute Inc. — Entity Name Discrepancy and Ownership Gap
The co-defendant entity in BC721131 is named 'Roxbury Surgical Institute Inc.' in the court caption. A separate directory source references 'Rodeo Surgical Institute Inc.' in connection with the subject's practice. Whether these are the same entity, a name change, or distinct organizations has not been resolved. California SOS primary-source lookup is required. No ownership or control link between Kohan and this entity has been confirmed. [VERIFIED PUBLIC — court caption; UNVERIFIED — entity identity and ownership]
Malpractice Dismissal Instrument Not Retrieved
The pre-trial dismissal of BC721131 is confirmed in docket sources, but the actual dismissal order has not been retrieved. Whether dismissal was with or without prejudice, and whether any monetary payment accompanied resolution, is an open gap. An NPDB inquiry would reveal whether a malpractice payment was reported. [VERIFIED PUBLIC — docket confirms dismissal; UNVERIFIED — terms of dismissal]
Primary-Source California Medical Board Verification Not Completed
Healthgrades reports no board action for the subject, but this is a secondary directory source. Primary-source BreEZe lookup with the California Medical Board has not been completed. The advisory cannot confirm a clean regulatory record on the basis of secondary-source absence alone. [REPORTED — Healthgrades (secondary); primary-source gap acknowledged]
Lipoplus Inc. — Lloyd Krieger Attribution Unconfirmed
Media reporting associates the federal trademark plaintiff Lipoplus Inc. with competing surgeon Lloyd Krieger. The named plaintiff in 2:2018cv10220 is the corporate entity Lipoplus Inc., not Krieger personally. Whether Krieger is an officer or principal of Lipoplus Inc. has not been confirmed through corporate records or court documents in the supplied research. Attribution of the action to Krieger individually must be treated as reported only. [REPORTED — The Real Deal LA; UNVERIFIED — Krieger's role in Lipoplus Inc.]
Scanner-Generated Adverse Characterization Requires Outcome Weighting
Automated adverse media screening tools flagged this subject as named in multiple lawsuits. This characterization is an aggregation artifact: the underlying matters, on decomposition, are a dismissed malpractice claim, an unresolved competitor IP action, and a landlord-side lease dispute. The scanner output is not an independent editorial finding and must not be relied upon without outcome weighting. [UNVERIFIED as editorial finding — scanner flag documented as aggregation artifact]
TikTok Search Cluster — Algorithmic Signal, Not Evidentiary
A platform-generated TikTok search cluster was noted in the supplied research as an algorithmic signal. No substantive patient harm narrative or corroborating content was identified. This signal is not an evidentiary finding. The consumer platform sweep required to assess this signal has not been completed and is an open investigative gap. [UNVERIFIED — algorithmic signal only; not carried into advisory as a finding]
Cedars-Sinai Affiliation Status — Directory vs Active Privileges
The Cedars-Sinai provider directory lists the subject as a provider. Active clinical privileges status, as distinct from a historical directory listing, has not been independently verified through Cedars-Sinai credentialing. For a due-diligence reader assessing the subject's current institutional standing, this distinction is material and is an open gap. [VERIFIED PUBLIC — directory listing; UNVERIFIED — active privileging status]
PACER primary-source retrieval of full docket for 2:2018cv10220 (Lipoplus Inc. v. Kohan) to confirm final order, settlement stipulation, or voluntary dismissal, and to verify Lloyd Krieger's relationship to Lipoplus Inc.
Primary-source California Medical Board BreEZe lookup for Emil Kohan MD to confirm license status, complaint history, and any disciplinary action; and National Practitioner Data Bank inquiry to determine whether any malpractice payment was reported in connection with BC721131.
California Secretary of State corporate records for Emil Kohan M.D. Inc. and Roxbury Surgical Institute Inc. to establish registered agent, officers, and any Kohan ownership interest, and to resolve the entity name discrepancy between 'Roxbury Surgical Institute Inc.' and 'Rodeo Surgical Institute Inc.'
Retrieval of the actual dismissal instrument from BC721131 to confirm whether dismissal was with or without prejudice, whether it was voluntary or court-ordered, and whether any payment accompanied resolution.
American Board of Plastic Surgery official directory primary-source verification of board certification status, certification year, and any lapse or restriction; plus structured consumer platform sweep of RealSelf, Google Reviews, Yelp, and Healthgrades for any harm narrative or complaint pattern not captured in formal legal records.
Emil J. Kohan, M.D. is a Beverly Hills plastic and reconstructive surgeon operating through a single California professional medical corporation, with a confirmed Cedars-Sinai Medical Center provider listing. The adverse record identified in this investigation is narrow, historically bounded, and dormant: a 2018 malpractice claim dismissed prior to trial with no liability finding, a 2018 federal competitor trademark action with unconfirmed resolution pending PACER verification, and a landlord-side commercial lease dispute reported in January 2019. No criminal charges, regulatory enforcement actions, sanctions-list entries, or professional licensing restrictions have been identified in available sources. The overall risk posture is borderline-low, warranting a watch-level notation pending closure of five identified primary-source verification gaps. The principal analytical risk in this profile is automated scanner overstatement of routine civil litigation, which this advisory disaggregates and contextualizes at its accurate evidentiary weight.
This advisory is produced for due-diligence and risk-assessment purposes. It reflects the state of publicly available information as of the research date. It does not constitute legal advice, a finding of guilt or liability, or a definitive regulatory assessment. All adverse claims are attributed to specific source documents with evidence-class labels. Material verification gaps are explicitly identified. The dismissal of BC721131 does not constitute an exoneration. The federal trademark matter requires PACER verification before any conclusion about outcome is warranted.
Low Risk · Tier A. The risk claims associated with Emil Kohan span three primary categories: dormant civil litigation (a dismissed malpractice action and a competitor trademark case with unconfirmed resolution), unverified corporate and entity relationships (the co-defendant status of Roxbury Surgical Institute Inc. and the Lipoplus/Krieger attribution question), and evidentiary gaps in primary-source regulatory verification (California Medical Board, ABPS, NPDB, and Cedars-Sinai privileging status). The overall risk posture is borderline-low, with no criminal, regulatory, or enforcement finding identified in available sources; the principal compliance concern is the unresolved status of the federal trademark case and the absence of primary-source regulatory verification rather than any confirmed adverse finding.
* This report is maintained as a living investigative record. Evidence is categorized by verification status and source type. User submissions are reviewed before inclusion.
Investigative Editor, Cross-Border Finance, based in London. Specializes in offshore structures, shell companies, trust arrangements, and beneficial ownership analysis.
This report is maintained as a living investigative record. Evidence is categorized by verification status and source type. User submissions are reviewed before inclusion.
Subjects, representatives, and counsel may submit additional or amended responses at any time. The channel remains open — every submission is reviewed manually before publication.
A restricted research workspace from Investigations.org — daily lead intake from twelve monitored source categories, scored and source-linked for human review.


GTV Media Group settled SEC charges for $539M after raising $452M in unregistered offerings. Founder convicted, sentenced 30 years. Investor fraud examined.
Former Binance UK head and Eqonex CEO named in dismissed SDNY securities class action. FCA raised beneficial-ownership concerns during his dual executive tenure.
Gstaad Brokers Ltd, offshore arm of FXVC/Finteractive, faces FCA enforcement, CySEC fines, licence revocation & alleged EU solicitation via Seychelles shell.
FCA-regulated eMerchantPay's auditor resigned citing governance failures. Reynisson faces alleged cybercrime links, Panama Papers listing, and regulatory blind spots.
SEC alleges Jonathan Adam ran a $61.5M crypto Ponzi scheme via GCZ Global LLC while concealing three prior felony convictions. Asset freeze imposed. Case expanding.
27 former employees allege Lubin stripped ConsenSys AG equity in a Swiss-to-Delaware restructuring. JPMorgan named co-defendant. SEC case closed, NY suit active.
A due-diligence map of the OFAC-designated Alex Saab network: Group Grand Limited across Hong Kong, Mexico and Dubai, the Saab brothers, and shells in Panama, Turkey and Colombia.
How Pennsylvania's Accelerated Rehabilitative Disposition clears a criminal charge without a conviction, and the limits that keep records visible to law enforcement and PennDOT, grounded in the Carla Risoldi diversion.
Carla Risoldi was charged in the 2015 Clairemont insurance-fraud case, then routed into diversion with no conviction. What the public record shows for due diligence.
Structured intelligence intake, watchlist tracking, custom alerts, and mobile access — and the means to underwrite the archive's independence.
Get Involved
We moderate comments to keep this a respectful and safe place. We have a zero-tolerance approach to user-to-user personal abuse. Please follow the house rules.
Participate in discussion, add context, and respond to this report.
* This discussion is moderated. Keep comments factual, relevant, and constructive. All submissions are reviewed before publication.
Submit verified tips, supporting evidence, or additional intelligence.
Request factual corrections or submit verifiable updates for this report.
* This discussion is moderated. Keep comments factual, relevant, and constructive. All submissions are reviewed before publication.
No comments yet. Be the first to comment!